Todd Franklin Watanabe Arcutis Biotherapeutics, Inc. (ARQT) insider trading activity

Todd Franklin Watanabe is Director of Arcutis Biotherapeutics, Inc.. Currently has a direct ownership of 913,795 shares of ARQT, which is worth approximately $12.4 Million. The most recent transaction as insider was on Feb 05, 2021, when has been sold 10,000 shares (Common Stock) at a price of $34.13 per share, resulting in proceeds of $341,300. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 914K

4.33% 3M change

6.16% 12M change

Total Value Held $12.4 Million

Todd Franklin Watanabe Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 05 2021	SELL Open market or private sale	$341,300 $34.13 p/Share	10,000 Reduced 1.73%	568,323 Common Stock
Feb 05 2021	BUY Exercise of conversion of derivative security	$16,800 $1.68 p/Share	10,000 Added 1.7%	578,323 Common Stock
Sep 29 2020	SELL Open market or private sale	$90,000 $30.0 p/Share	3,000 Reduced 0.53%	566,928 Common Stock
Sep 29 2020	SELL Open market or private sale	$90,000 $30.0 p/Share	3,000 Reduced 0.53%	566,928 Common Stock
Sep 29 2020	BUY Exercise of conversion of derivative security	$5,040 $1.68 p/Share	3,000 Added 0.52%	569,928 Common Stock
Sep 29 2020	BUY Exercise of conversion of derivative security	$5,040 $1.68 p/Share	3,000 Added 0.52%	569,928 Common Stock

TFW

Todd Franklin Watanabe

Director

Westlake Village, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARQT shares.

Notify only if

Value

Insider Trading

Get notified when an Arcutis Biotherapeutics, Inc. insider buys or sells ARQT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Arcutis Biotherapeutics, Inc.

Track Activities on ARQT

Account